Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06437301 · ClinicalTrials.gov registry record · NA
End Tidal CO2 and Masks: Is There a Correlation?
A NA study, sponsored by CHRISTUS Health.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT06437301 is a NA study that has completed, run by CHRISTUS Health. The registered enrollment target is 31 participants.
The verdict
NCT06437301, a NA study, has completed, sponsored by CHRISTUS Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
In light of the ongoing COVID-19 pandemic, wearing a mask has become a universal standard as an attempt to reduce the spread of COVID-19. As of 2020, more than half of all U.S. states have implemented a state wide mandated mask policy. There are many schools of thought regarding the benefits and risks of donning a mask to prevent the spread of COVID-19. There is an unproven theory among some that wearing a mask interferes with our natural respiratory function, causing hypoxia, altered mental status and other various health issues. This dangerous perception has led some to believe wearing a mask is harmful, and encourages against wearing a mask in public. This theory, recently refuted by a study investigating oxygen levels while participants wore masks, performed in 2020 encouraged increased compliance with wearing masks. Another study, preformed by evaluated whether gas exchange abnormalities occurred with the use of surgical masks in subjects with and without lung function impairment. The conclusions of the study showed that regardless of lung function impairment, the presence of surgical masks did not impact gas exchange. Additionally, a more recent study concluded that the presence of a facemask did not have a significant change in physiologic parameters while during exercise. Although there is evidentiary support that facemasks do not negatively affect oxygen status and physiologic capacity, there is not strong evidence examining the relationship between ETCO2 and facemasks. The relationship between ETCO2 and facemasks is one of importance because mild decreases in oxygen have much less dangerous effects compared to the effects of rapid accumulations of carbon dioxide. Increases in end tidal carbon dioxide lead to confusion, acidosis and in severe cases, respiratory distress and failure. A study performed in 1989 showed that hypercapnia has greater increases in blood pressure, minute ventilation and sympathetic nerve activity than hypoxia. In this newly propose
Interventions
- OTHER Baseline measure of ETCO2 without mask
- OTHER Baseline ETCO2 with mask
- OTHER ETCO2 after 200 meter walk with mask
- OTHER ETCO2 after 200 meter walk without mask
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2021-07-01 |
| Est. Completion | 2022-03-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06437301
The ClinicalTrials.gov registry entry for NCT06437301 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CHRISTUS Health, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Baseline measure of ETCO2 without mask is the first listed.
NCT06437301 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06437301 about?
NCT06437301 is a clinical study titled "End Tidal CO2 and Masks: Is There a Correlation?". In light of the ongoing COVID-19 pandemic, wearing a mask has become a universal standard as an attempt to reduce the spread of COVID-19. As of 2020, more than half of all U.S. states have implemented a state wide mandated mask policy. There are many schools of thought regarding the benefits and ris...
What is the current status of trial NCT06437301?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2021-07-01. Estimated completion is 2022-03-16.
What interventions are being tested in trial NCT06437301?
The interventions under investigation include: Baseline measure of ETCO2 without mask (OTHER), Baseline ETCO2 with mask (OTHER), ETCO2 after 200 meter walk with mask (OTHER), ETCO2 after 200 meter walk without mask (OTHER).
Who is sponsoring clinical trial NCT06437301?
This trial is sponsored by CHRISTUS Health, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.